ProofPilot, the leading end-to-end clinical experience platform, announces the acquisition of Lokavant, the clinical trial intelligence company and the premier provider of predictive analytics for clinical research. This acquisition combines ProofPilot’s powerful trial execution capabilities with Lokavant’s advanced analytics, creating an unparalleled platform for sponsors and research organizations to optimize clinical research and accelerate the delivery of new therapies. Spun out of Roivant in 2020, Lokavant’s technology leverages historical and real-time data to deliver predictive insights, optimize study feasibility, and mitigate operational risk in study conduct.
Read the full article: ProofPilot Acquires Lokavant to Transform Clinical Trial Performance with Predictive Analytics //
Source: https://www.prnewswire.com/news-releases/proofpilot-acquires-lokavant-to-transform-clinical-trial-performance-with-predictive-analytics-302555757.html